{
  "trial_id": "NCT00585689",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, serum creatinine, creatinine clearance, granulocyte count, platelet count, hemoglobin level, AST level, ALT level, alkaline phosphatase level, bilirubin level, presence of pre-existing peripheral neuropathy, prior malignancy history, presence of bacterial infection, pregnancy status, use of contraceptive method.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Performance Status (ECOG)",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Clinical Disease Stage",
        "Hydronephrosis Present",
        "Angiolymphatic Invasion Present",
        "Adjacent Carcinoma in Situ Present",
        "Mixed Histological Features Present"
      ],
      "remaining_candidate_features": [
        "serum creatinine",
        "creatinine clearance",
        "granulocyte count",
        "platelet count",
        "hemoglobin level",
        "AST level",
        "ALT level",
        "alkaline phosphatase level",
        "bilirubin level",
        "presence of pre-existing peripheral neuropathy",
        "prior malignancy history",
        "presence of bacterial infection",
        "pregnancy status",
        "use of contraceptive method."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, ECOG Performance Status, Serum Creatinine, Creatinine Clearance, Granulocyte Count, Platelet Count, Hemoglobin Level, AST, ALT, Alkaline Phosphatase, Bilirubin Level, Pre-existing Peripheral Neuropathy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Performance Status (ECOG)",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Clinical Disease Stage",
        "Hydronephrosis Present",
        "Angiolymphatic Invasion Present",
        "Adjacent Carcinoma in Situ Present",
        "Mixed Histological Features Present"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Serum Creatinine",
        "Creatinine Clearance",
        "Granulocyte Count",
        "Platelet Count",
        "Hemoglobin Level",
        "AST",
        "ALT",
        "Alkaline Phosphatase",
        "Bilirubin Level",
        "Pre-existing Peripheral Neuropathy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Serum Creatinine, Granulocyte Count, Platelet Count, Hemoglobin, AST, ALT, Alkaline Phosphatase, Bilirubin, Peripheral Neuropathy, Prior Malignancy, Prior Surgery, Prior Radiotherapy, Prior Chemotherapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Performance Status (ECOG)",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Clinical Disease Stage",
        "Hydronephrosis Present",
        "Angiolymphatic Invasion Present",
        "Adjacent Carcinoma in Situ Present",
        "Mixed Histological Features Present"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Serum Creatinine",
        "Granulocyte Count",
        "Platelet Count",
        "Hemoglobin",
        "AST",
        "ALT",
        "Alkaline Phosphatase",
        "Bilirubin",
        "Peripheral Neuropathy",
        "Prior Malignancy",
        "Prior Surgery",
        "Prior Radiotherapy",
        "Prior Chemotherapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, performance status (ECOG), histological subtype of urothelial carcinoma, tumor stage (T2-4, N0, M0 or Tany, N1-3, M0), serum creatinine, creatinine clearance, granulocyte count, platelet count, hemoglobin, AST, ALT, alkaline phosphatase, bilirubin, presence of peripheral neuropathy, prior surgery, reproductive status (for women).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Performance Status (ECOG)",
          "performance status (ECOG)"
        ],
        [
          "Clinical Disease Stage",
          "tumor stage (T2-4, N0, M0 or Tany, N1-3, M0)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Hydronephrosis Present",
        "Angiolymphatic Invasion Present",
        "Adjacent Carcinoma in Situ Present",
        "Mixed Histological Features Present"
      ],
      "remaining_candidate_features": [
        "race",
        "histological subtype of urothelial carcinoma",
        "serum creatinine",
        "creatinine clearance",
        "granulocyte count",
        "platelet count",
        "hemoglobin",
        "AST",
        "ALT",
        "alkaline phosphatase",
        "bilirubin",
        "presence of peripheral neuropathy",
        "prior surgery",
        "reproductive status (for women)"
      ]
    }
  }
}